Evaluation and follow-up program for vascular liver diseases
Official title: Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program
Run by University Hospital, Bonn · NCT03717792 · Data updated 2026-11-12
This study looks at patients with vascular liver diseases to better understand their risk factors, treatment effects, and overall health outcomes over three years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University Hospital, Bonn Academic / other |
| Locations | 1 site (Bonn) |
| Status | Recruiting |
| Started | January 1, 2010 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2027 |
| Registry record updated | October 5, 2021 |
| Trial ID | NCT03717792 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this program are patients diagnosed with vascular liver disease.
✕Probably not a fit
Patients without vascular liver disease will not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program aims to improve understanding of vascular liver disorders (VALDI) by studying risk factors, diagnostic methods, treatment effects, and prognosis. Data will be collected from patients diagnosed with VALDI over a period of up to three years, focusing on clinical conditions, laboratory results, and outcomes. The study employs a standardized review of medical charts conducted by a specially trained investigator to ensure accurate and comprehensive data collection.
Why it matters
Potential benefit: If successful, this program could lead to improved management recommendations for patients with vascular liver diseases.
How similar studies have gone: Previous studies on vascular liver disorders have been limited and retrospective, making this prospective observational approach novel and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients with vascular liver disease Exclusion Criteria: * patients without vascular liver disease
Where it's running
-
University Hospital Bonn
Bonn, Germany Recruiting
Study contacts
- Principal investigator: Michael Praktiknjo, MD — University of Bonn
- Study coordinator: Michael Praktiknjo, MD
- Email: michael.praktiknjo@ukbonn.de
- Phone: +4922828715770
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How knee and hip joint replacements are doing over time
This observational study follows adults who have knee or hip replacements to see how their outcomes look over time after the surgery.
-
Enhanced vision and imaging tests to enable treatments for early and intermediate AMD
We will see if a fundus-tracked dark adaptometry test can reliably detect and track vision changes in people with early or intermediate AMD and in healthy volunteers.
-
Increasing daily physical activity to slow cognitive decline in alpha-synuclein disorders
This study will test whether using a motivational smartphone app to increase everyday physical activity can help slow cognitive decline in people aged 50–80 with isolated REM sleep behavior disorder (an early sign of alpha‑synuclein disease).
-
Microdialysis monitoring of antibiotic release after hip spacer surgery
This project will use microdialysis to test whether antibiotics released from a cement spacer reach therapeutic levels in the hip joint and relate to infection-free recovery in adults having two-stage revision for periprosthetic hip infection.
-
Monitoring antibiotic and immune activity in the knee after removal of an infected prosthesis and placement of an antibiotic spacer
This project will use microdialysis to see if antibiotic levels and immune signals in the knee after spacer placement predict infection-free recovery for people having a two-stage revision for periprosthetic knee infection.
-
Blood Flow Restriction Training for older adults in acute rehabilitation
This trial tests whether blood flow restriction training on a stationary bike can help improve muscle mass and general health in people over 65 during two weeks of acute geriatric rehabilitation after hip-related injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.